Duration of ADT and EBRT With or Without Brachytherapy for Optimal Treatment of High-Risk Prostate Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer: A Patient-Level Data Analysis of 3 Cohorts
JAMA Oncol 2022 Jan 20;[EPub Ahead of Print], AU Kishan, A Steigler, JW Denham, A Zapatero, A Guerrero, D Joseph, X Maldonado, JK Wong, BJ Stish, RT Dess, A Pilar, C Reddy, TB Wedde, WA Lilleby, R Fiano, GS Merrick, RG Stock, DJ Demanes, BJ Moran, PT Tran, S Martin, R Martinez-Monge, DJ Krauss, EI Abu-Isa, TM Pisansky, CR Choo, DY Song, S Greco, C Deville, T McNutt, TL DeWeese, AE Ross, JP Ciezki, D Tilki, RJ Karnes, JJ Tosoian, NG Nickols, P Bhat, D Shabsovich, JE Juarez, T Jiang, TM Ma, M Xiang, R Philipson, A Chang, PA Kupelian, MB Rettig, FY Feng, A Berlin, JD Tward, BJ Davis, RE Reiter, ML Steinberg, D Elashoff, PC Boutros, EM Horwitz, RD Tendulkar, DE Spratt, T RomeroFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.